Nykredit A S Takes Position in Danaher Corporation $DHR

Key Points

• Nykredit A/S acquired 159,476 Danaher shares during the second quarter, valued at approximately $30.4 million. Institutional investors and hedge funds collectively own 79.05% of Danaher’s outstanding stock.
• Analysts maintain a positive outlook, with Danaher receiving a consensus “Moderate Buy” rating and an average price target of $228.91; recent targets range from $200 to $250.
• Danaher reported quarterly earnings of $1.94 per share and revenue of $6.26 billion, exceeding estimates, while revenue rose 5.5% year over year. The company also declared a quarterly dividend of $0.40 per share, representing a 0.8% annualized yield.

Nykredit A S acquired a new position in shares of Danaher Corporation (NYSE:DHR - Free Report) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 159,476 shares of the conglomerate's stock, valued at approximately $30,377,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the company. Main Street Group LTD acquired a new position in Danaher during the first quarter valued at approximately $25,000. N.E.W. Advisory Services LLC acquired a new stake in shares of Danaher in the second quarter worth $25,000. Hilton Head Capital Partners LLC bought a new position in Danaher during the fourth quarter worth $27,000. Clal Insurance Enterprises Holdings Ltd raised its position in shares of Danaher by 71.6% during the fourth quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate's stock valued at $29,000 after buying an additional 53 shares during the last quarter. Finally, Evolution Wealth Management Inc. lifted its stake in shares of Danaher by 208.0% in the first quarter. Evolution Wealth Management Inc. now owns 154 shares of the conglomerate's stock valued at $29,000 after buying an additional 104 shares during the period. Hedge funds and other institutional investors own 79.05% of the company's stock.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on DHR shares. Citigroup assumed coverage on shares of Danaher in a research note on Tuesday, May 26th. They issued a "buy" rating and a $230.00 price objective for the company. Piper Sandler assumed coverage on shares of Danaher in a research note on Thursday, June 11th. They set a "neutral" rating and a $200.00 price target for the company. UBS Group started coverage on Danaher in a report on Wednesday, September 9th. They set a "buy" rating and a $250.00 price objective on the stock. Weiss Ratings raised Danaher from a "hold (c-)" rating to a "hold (c)" rating in a report on Wednesday. Finally, Royal Bank Of Canada raised their target price on Danaher from $200.00 to $215.00 and gave the stock an "outperform" rating in a research report on Wednesday, July 22nd. Two equities research analysts have rated the stock with a Strong Buy rating, eighteen have given a Buy rating and five have given a Hold rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $228.91.

Danaher Stock Down 0.4%

Shares of NYSE DHR opened at $211.59 on Friday. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65. The stock has a market cap of $148.74 billion, a P/E ratio of 37.58, a P/E/G ratio of 2.65 and a beta of 0.78. The firm has a 50 day moving average price of $204.09 and a 200 day moving average price of $192.05.

Danaher (NYSE:DHR - Get Free Report) last posted its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, topping the consensus estimate of $1.85 by $0.09. The firm had revenue of $6.26 billion for the quarter, compared to analyst estimates of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The company's revenue for the quarter was up 5.5% on a year-over-year basis. During the same period in the previous year, the company posted $0.77 earnings per share. Analysts expect that Danaher Corporation will post 8.53 EPS for the current year.

Danaher Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th will be issued a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 0.8%. The ex-dividend date of this dividend is Wednesday, September 30th. Danaher's dividend payout ratio is presently 28.42%.

About Danaher

Danaher Corporation NYSE: DHR is a global science and technology company that develops products, services and solutions for the life sciences, biotechnology and diagnostics markets. Its businesses support pharmaceutical and biotechnology research, biomanufacturing, clinical laboratories and healthcare providers.

The company's portfolio includes bioprocessing technologies, laboratory instruments, consumables, reagents and software. Key businesses include Cytiva, which provides biomanufacturing solutions; Beckman Coulter, which supplies laboratory diagnostics and automation systems; Leica Biosystems, which develops pathology products; and IDT, which provides genomic and nucleic acid products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.